ArticleExperimental and therapeutic medicine2023

Late‑onset immune checkpoint inhibitor‑related pneumonitis after cessation of sintilimab: A case report and literature review.

Yupei Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.